US President Donald Trump crows over win in bitter Supreme Court battle

Agencies
October 9, 2018

Washington, Oct 9: President Donald Trump prepared a triumphant swearing-in ceremony for his new conservative Supreme Court justice Monday and called sexual assault allegations against Brett Kavanaugh a "hoax." Following arguably the biggest - and hardest-fought - victory of his controversy-strewn presidency, Trump was crowing.

Kavanaugh's Saturday confirmation in one of the closest such Senate votes in history highlighted deep American polarization ahead of November 6 congressional midterm elections where Democrats hope to end Republican dominance. But far from using the aftermath of the battle to try and heal the nation, Trump piled into even fiercer attacks. Boarding the Marine One helicopter at the White House, he branded the sexual assault allegations that threatened to derail Kavanaugh's path to the top court "a hoax" and "all made up, fabricated."

Democrats, Trump said, "tortured him (Kavanaugh) and his family. I thought it was a disgrace." The president - whose Republicans fear losing at least the lower chamber of Congress in November - angrily predicted that the Kavanaugh row would backfire on Democrats. "I think a lot of Democrats are going to vote Republican," he said. "I think you're going to see a lot of things happening on November 6 that wouldn't have."

Democrats fought tooth and nail to stop Kavanaugh's candidacy, claiming that the accomplished, conservative-minded judge was not suited to the Supreme Court, which will now tilt decisively to a more Republican-friendly panel. Then, just as his confirmation seemed inevitable, 11th-hour allegations emerged that Kavanaugh sexually assaulted a 15-year-old girl while at high school and exposed himself to a female classmate at an alcohol-fueled dorm party at Yale University.

No concrete evidence was produced to back up the searing accusations. Then an extra FBI probe - which media reports say was drastically curtailed by the White House -- also found nothing new and Kavanaugh was finally voted into the coveted post. Late Monday, Trump was set to rub salt into opponents' wounds by hosting a formal swearing-in ceremony.

Kavanaugh officially took the oath in a more hurried, private procedure Saturday, but the White House version will be a chance for the Trump administration to celebrate publicly.

High stakes

Trump told a conference of police chiefs in Florida that he considered overseeing the ceremony an "honor." He called the Kavanaugh row "a disgraceful situation brought about by people who are evil," and said that the result was "very exciting." "I'm doing rallies and people are loving that man and loving that choice," he told the police audience.

In reality, Kavanaugh's confirmation lit a match under existing left-right tensions. The two-vote margin of victory in the Senate made it the closest Supreme Court confirmation vote since 1881 - and by far the most contentious since Clarence Thomas in 1991. Only one Democrat voted for Trump's nominee.

Kavanaugh's nomination as a replacement for retired justice Anthony Kennedy - long seen as a key swing vote - was controversial from the start. The initial focus of opposition was solely on the conservative views held by the married father of two. Then came bombshell testimony from university research psychologist Christine Blasey Ford that Kavanaugh had sexually assaulted her at a gathering when they were in school.

Now that Kavanaugh is confirmed, the nine-justice court, which rules on constitutional questions, is expected to take a more reliably conservative approach. Trump has repeatedly said that putting conservatives on the court - Kavanaugh is his second appointment - was among the top goals of his presidency. Since justices serve lifetime appointments, the political consequences are likely to last long beyond Trump's administration.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
July 7,2020

Washington, Jul 7: US Secretary of State Mike Pompeo on Monday (local time) confirmed that the White House is "looking at" banning the Chinese social media apps including TikTok.

"With respect to Chinese apps on people's cell phones, I can assure you the United States will get this one right too. I don't want to get out in front of the President [Donald Trump], but it's something we're looking at," Pompeo was quoted by CNN during an interview with Fox News.

He said people should only download the app, "if you want your private information in the hands of the Chinese Communist Party."

Responding to his comments, a TikTok spokesperson said, "TikTok is led by an American CEO, with hundreds of employees and key leaders across safety, security, product and public policy here in the US."

"We have no higher priority than promoting a safe and secure app experience for our users.  We have never provided user data to the Chinese government, nor would we do so if asked," the spokesperson added.

The US politicians have repeatedly criticised TikTok, owned by Beijing-based startup ByteDance, of being a threat to national security because of its ties to China.

Recently, India banned 59 Chinese apps including TikTok following a violent standoff with Chinese troops. This move was lauded by the US officials.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 6,2020

Tokyo, April 6: Japan Prime Minister Shinzo Abe is planning to declare a state of emergency in view of the surging cases of coronavirus in the country, especially in Tokyo and other large cities, government sources said on Monday.

Pressure had been mounting on Abe to make the declaration amid a spurt in COVID-19 cases recently, with calls for the move from Tokyo Governor Yuriko Koike and the Japan Medical Association intensifying, Xinhua news agency reported.

The Tokyo metropolitan government, along with healthcare specialists, said that the number of hospital beds available for coronavirus patients will soon reach capacity, with the health ministry rapidly trying to secure more beds.

Adding to pressure on the government to demonstrably bolster its preventive and countermeasures to the spread of the virus, a panel of government experts warned recently that the country's healthcare system could collapse if coronavirus cases continue to spike.

The healthcare system in Tokyo and four other prefectures are under increased strain and "drastic countermeasures need to be taken as quickly as possible," the experts said.

As of Sunday, 143 new cases of COVID-19 were recorded in Tokyo, a record daily high for the capital, bringing the total to 1,034, with Japan's health ministry and local governments adding that nationwide cases rose to 3,531 as of Sunday afternoon.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

Beijing/Zurich, Mar 4: China has approved the use of Swiss drugmaker Roche's anti-inflammation drug Actemra for patients who develop severe complications from the coronavirus as it urgently hunts for new ways to combat the deadly infection that is spreading worldwide.

China is hoping that some older drugs could stop severe cytokine release syndrome (CRS), or cytokine storms, an overreaction of the immune system which is considered a major factor behind catastrophic organ failure and death in some coronavirus patients.

Actemra, a biologic drug approved in 2010 in the United States for rheumatoid arthritis (RA), inhibits high Interleukin 6 (IL-6) protein levels that drive some inflammatory diseases.

China's National Health Commission said in treatment guidelines published online on Wednesday that Actemra can now be used to treat coronavirus patients with serious lung damage and high IL-6 levels.

Separately, researchers in the country are testing Actemra, known generically as tocilizumab, in a clinical trial expected to include 188 coronavirus patients and running until May 10.

Roche, which donated 14 million yuan ($2.02 million) worth of Actemra during February, said the trial was initiated independently by a third party with the aim of exploring the efficacy and safety of the drug in coronavirus patients with CRS.

It added that there was currently no published clinical trial data on the drug's safety or efficacy against the virus.

More than 3,000 people have died and 93,000 have been infected by the novel coronavirus thought to have originated in Wuhan, China, before spreading to around 90 countries including the United States, Italy, Switzerland, France and Germany.

The Swiss company, for which China is its No. 2 market behind the United States, also makes diagnostic gear to detect the coronavirus.

Since Actemra's approval a decade ago, it has become a go-to drug against other inflammatory conditions, including cytokine storms in cancer patients receiving cell therapies from Novartis and Gilead Sciences.

In 2012 it helped save the life of a young U.S. girl, the first child to be treated for leukaemia with Novatis' Kymriah, from a post-treatment rush of IL-6.

Priced at between $20-30,000 annually for RA according to SSR Health, Roche's medicine is also used for rare juvenile arthritis and giant cell arteritis, or inflammation of the blood vessels.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.